D. E. Shaw & Co., Inc. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2022$2,352,000
-47.4%
351,039
-50.1%
0.00%
-40.0%
Q2 2022$4,474,000
+51.3%
703,478
+10.4%
0.01%
+66.7%
Q1 2022$2,958,000
-34.0%
637,436
-28.9%
0.00%
-25.0%
Q4 2021$4,485,000
+945.5%
896,972
+2421.1%
0.00%
Q3 2021$429,000
-17.5%
35,579
+77.9%
0.00%
Q4 2020$520,000
-30.0%
20,0000.0%0.00%
-100.0%
Q3 2020$743,000
-27.6%
20,0000.0%0.00%0.0%
Q2 2020$1,026,000
+19.9%
20,000
-26.3%
0.00%0.0%
Q1 2020$856,000
-86.6%
27,125
-74.6%
0.00%
-85.7%
Q4 2019$6,379,000
+25.1%
106,975
-23.1%
0.01%
+16.7%
Q3 2019$5,099,000
+56.5%
139,090
+98.6%
0.01%
+20.0%
Q2 2019$3,259,000
+179.0%
70,034
+140.7%
0.01%
+150.0%
Q1 2019$1,168,000
-39.4%
29,100
-30.5%
0.00%
-33.3%
Q4 2018$1,927,000
-12.6%
41,900
-15.7%
0.00%0.0%
Q3 2018$2,205,000
-23.0%
49,697
-32.0%
0.00%
-25.0%
Q2 2018$2,865,000
+103.8%
73,100
+276.1%
0.00%
+100.0%
Q1 2018$1,406,000
+104.4%
19,434
+85.9%
0.00%
+100.0%
Q4 2017$688,000
+121.9%
10,456
-57.8%
0.00%0.0%
Q4 2016$310,000
-57.2%
24,796
-52.6%
0.00%0.0%
Q3 2016$725,000
+207.2%
52,339
+423.4%
0.00%
Q3 2015$236,000
-82.5%
10,000
-39.4%
0.00%
-100.0%
Q2 2015$1,349,000
+16.1%
16,500
+31.5%
0.00%0.0%
Q1 2015$1,162,00012,5470.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders